These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6543129)

  • 41. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure-pharmacokinetics relationship of series of aminosteroidal neuromuscular blocking agents in the cat.
    Proost JH; Wierda JM; Houwertjes MC; Roggeveld J; Meijer DK
    J Pharmacol Exp Ther; 2000 Mar; 292(3):861-9. PubMed ID: 10688598
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.
    Raynaud FI; Boxall FE; Goddard P; Barnard CF; Murrer BA; Kelland LR
    Anticancer Res; 1996; 16(4A):1857-62. PubMed ID: 8712713
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic and metabolic studies of vinpocetine on dogs. I. Pharmacokinetics.
    Szeleczky G; Vereczkey L
    Pol J Pharmacol Pharm; 1986; 38(3):257-67. PubMed ID: 3774624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.
    Bregante MA; Saez P; Aramayona JJ; Fraile L; Garcia MA; Solans C
    Am J Vet Res; 1999 Sep; 60(9):1111-6. PubMed ID: 10490081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
    Nakagawa T; Ishigai M; Kato M; Hayakawa N; Kinoshita H; Okutomi T; Ohkubo K; Okazaki A
    Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic and metabolic studies of the hypoxic cell radiosensitizer misonidazole.
    Flockhart IR; Large P; Troup D; Malcolm SL; Marten TR
    Xenobiotica; 1978 Feb; 8(2):97-105. PubMed ID: 415443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma pharmacokinetics and urinary excretion of the polyamine analogue 1, 19-bis(ethylamino)-5, 10, 15-triazanonadecane in CD2F1 mice.
    Eiseman JL; Yuan ZM; Eddington ND; Sentz DL; Callery PS; Egorin MJ
    Cancer Chemother Pharmacol; 1996; 38(1):13-20. PubMed ID: 8603446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of daunorubicinol in the rabbit: comparison with daunorubicin.
    Maniez-Devos DM; Baurain R; Trouet A; Lesne M
    J Pharmacol; 1986; 17(1):14-20. PubMed ID: 3713197
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biotransformation and pharmacokinetics of the nitrate trans-2-amino-2-methyl-N-(4-nitroxycyclohexyl)-propionamide in dogs.
    Pressmar F; Neidlein R; Strein K
    Arzneimittelforschung; 1992 Nov; 42(11):1306-11. PubMed ID: 1492842
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Absorption, tissue distribution, and excretion of the anti-neoplastic agent guanazole in the rat.
    Musa MN; Lower GM; Welling PG; Johnson BM; Kaiman BD; Bryan GT
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):497-512. PubMed ID: 4824824
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of fluorescent trypanocidal diamidines by quantitative thin-layer chromatography.
    Gluth WP; Kaliwoda G; Dann O
    J Chromatogr; 1986 May; 378(1):183-93. PubMed ID: 3733971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Development of proxibarbal blood levels. The role of various elimination processes].
    Lambrey B; Lafont O; D'Athis P; Jacquot C
    J Pharmacol; 1984; 15(2):223-30. PubMed ID: 6145815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals.
    Oliverio VT; Vietzke WM; Williams MK; Adamson RH
    Cancer Res; 1970 May; 30(5):1330-7. PubMed ID: 4987693
    [No Abstract]   [Full Text] [Related]  

  • 55. The metabolism of chlorpheniramine maleate in the dog and rat.
    Peets EA; Weinstein R; Billard W; Symchowicz S
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):172-90. PubMed ID: 5072184
    [No Abstract]   [Full Text] [Related]  

  • 56. [Kinetics of the excretion of a membrane-active macroheterocycle from the body in mice].
    Plotnikova EK; Golovenko NIa; Zin'kovskiĭ VG; Luk'ianenko NG; Zhuk OV
    Farmakol Toksikol; 1986; 49(4):64-7. PubMed ID: 3758332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Studies of the disposition and metabolism of mefloquine HCl (WR 142,490), a quinolinemethanol antimalarial, in the rat. Limited studies with an analog, WR 30,090.
    Mu JY; Israili ZH; Dayton PG
    Drug Metab Dispos; 1975; 3(3):198-210. PubMed ID: 238819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
    Godeneche D; Madelmont JC; Moreau MF; Duprat J; Chabard JL; Plagne R; Meyniel G
    Drug Metab Dispos; 1985; 13(2):220-6. PubMed ID: 2859172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies in cattle on the disposition of the anti-trypanosomal drug diminazene diaceturate (Berenil).
    Kellner HM; Eckert HG; Volz MH
    Trop Med Parasitol; 1985 Dec; 36(4):199-204. PubMed ID: 4089474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetics, tissue distribution, and biotransformation of a new class of antitumor agents: mitonafide and pinafide.
    Rivera Cid P; Gonzalez Fernandez E; Martin FR; Braña MF
    Eur J Drug Metab Pharmacokinet; 1986; 11(4):255-67. PubMed ID: 3582420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.